entanglement in self-assembling β-peptide nanofibres decorated with vancomycin.

The increasing resistance of pathogenic microbes to antimicrobials and the shortage of antibiotic drug discovery programs threaten the clinical use of antibiotics. This threat calls for the development of new methods for control of drug-resistant microbial pathogens. We have designed, synthesised and characterised an antimicrobial material formed the self-assembly of a population of two distinct β-peptide monomers, a lipidated tri-β-peptide (β-peptide) and a novel β-peptide conjugated to a glycopeptide antibiotic, vancomycin.